Healthstream (HSTM) Common Equity (2010 - 2026)

Healthstream (HSTM) has 17 years of Common Equity data on file, last reported at $352.0 million in Q1 2026.

• Common Equity for Q1 2026 came in at $352.0 million, down 2.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $352.0 million (down 2.98% YoY), and the FY2025 annual result was $354.0 million, down 1.48% from the prior year.
• Common Equity declined to $352.0 million in Q1 2026 per HSTM's latest filing, from $354.0 million in the prior quarter.
• Over five years, Common Equity peaked at $362.8 million in Q1 2025 and troughed at $322.6 million in Q1 2022.
• A 5-year average of $344.2 million and a median of $344.9 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2024: Common Equity retreated 4.23% in 2022, then advanced 5.46% in 2024.
• A 5-year view of Common Equity shows it stood at $334.1 million in 2022, then grew by 2.0% to $340.8 million in 2023, then increased by 5.46% to $359.4 million in 2024, then retreated by 1.48% to $354.0 million in 2025, then decreased by 0.57% to $352.0 million in 2026.
• Business Quant data shows HSTM's Common Equity at $352.0 million in Q1 2026, $354.0 million in Q4 2025, and $349.2 million in Q3 2025.